US 11191813
Lyophilized recombinant VWF formulations
granted A61KA61K38/16A61K38/17
Quick answer
US patent 11191813 (Lyophilized recombinant VWF formulations) held by Takeda Pharmaceutical Company Limited expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/16, A61K38/17, A61K38/36, A61K47/12